Researchers at McGill University have made an important step forward in understanding the cause of a rare neurodegenerative disease noted for its occurrence in the Charlevoix and Saguenay鈥揕ac-Saint-Jean regions of Quebec.
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a genetic condition that affects coordination and balance from early childhood. Most ARSACS patients require a wheelchair by the time they reach their 30s or 40s. There is no cure and current treatments provide only limited symptomatic relief.
